The global seasonal influenza vaccines therapeutics market has witnessed robust growth in recent years, culminating in a significant valuation of approximately USD 7.2 Billion by the end of 2021. This market, driven by the escalating prevalence of seasonal flu and continuous advancements in vaccine technology, is projected to surge at an impressive Compound Annual Growth …